Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Henriquez-Camacho C, Serre N, Norman F, Sánchez-Montalvá A, Torrús D, Goikoetxea AJ, Herrero-Martínez JM, Ruiz-Giardín JM, Treviño B, Monge-Maillo B, Molina I, Rodríguez A, García M, López-Vélez R, Pérez-Molina JA.
Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network.
TRAVEL MEDICINE AND INFECTIOUS DISEASE . 29: 51-57. Nº de citas: 3
-
Pintado V, Pazos R, Jiménez-Mejías ME, Rodríguez-Guardado A, Díaz-Pollán B, Cabellos C, García-Lechuz JM, Lora-Tamayo J, Domingo P, Muñez E, Domingo D, González-Romo F, Lepe-Jiménez JA, Rodríguez-Lucas C, Gil A, Pelegrín I, Chaves F, Pomar V, Ramos A, Alarcón T, Pérez-Cecilia E.
Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains.
JOURNAL OF HOSPITAL INFECTION . 102(1): 108-115. Nº de citas: 5
-
Soto-Castillo JJ, Fortún-Abete J, Soria-Rivas A.
Black ulcer in leg.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(5): 344-346.
-
Ruiz-Mateos E, Ruiz-León MJ, Tarancón-Díez L, Gutiérrez C, Dronda F, Domínguez-Molina B, Pérez-Elías MJ, Moreno A, Leal M, Moreno S, Vallejo A.
High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.
VIRUS RESEARCH . 264: 40-44. Nº de citas: 3
-
López-Huertas MR, Palladino C, Garrido-Arquero M, Esteban-Cartelle B, Sánchez-Carrillo M, Martínez-Román P, Martín-Carbonero L, Ryan P, Domínguez-Domínguez L, Santos IL, Moral SF, Benito JM, Rallón N, Alcamí J, Resino S, Fernández-Rodríguez A, Coiras M, Briz V, Multidisciplinary Group of viral coinfection HIV/Hepatitis (COVIHEP).
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study.
SCIENTIFIC REPORTS . 9(1): 5606-5606. Nº de citas: 12
-
Milic, Jovana, Russwurm, Magdalena, Cerezales Calvino, Ana, Branas, Fatima, Sanchez-Conde, Matilde, Guaraldi, Giovanni.
European cohorts of older HIV adults: POPPY, AGE(h)IV, GEPPO, COBRA and FUNCFRAIL
EUROPEAN GERIATRIC MEDICINE . 10(2): 247-257. Nº de citas: 7
-
Sanchez-Conde, Matilde, Diaz-Alvarez, Jorge, Dronda, Fernando, Branas, Fatima.
Why are people with HIV considered "older adults" in their fifties?
EUROPEAN GERIATRIC MEDICINE . 10(2): 183-188. Nº de citas: 3
-
Vivancos, Maria J., Martinez-Sanz, Javier, Moreno, Santiago.
HIV infection epidemiology: a change of scenery
EUROPEAN GERIATRIC MEDICINE . 10(2): 169-174. Nº de citas: 2
-
Casado JL, Monsalvo M, Fontecha M, Vizcarra P, Rodriguez MA, Vivancos MJ, Moreno S.
Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting.
HIV RESEARCH & CLINICAL PRACTICE . 20(2): 64-72. Nº de citas: 7
-
Venanzi E, Martín-Dávila P, López J, Maiz L, de la Pedrosa EG, Gioia F, Escudero R, Filigheddu E, Moreno S, Fortún J.
Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience.
Mycopathologia . 184(2): 239-250. Nº de citas: 4
-
Moreno S, Perno CF, Mallon PW, Behrens G, Corbeau P, Routy JP, Darcis G.
Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?
HIV MEDICINE . 20 Suppl 4: 2-12. Nº de citas: 27
-
Fontecha M, Monsalvo M, Rodriguez-Sagrado MA, Vivancos MJ, Moreno A, Casado JL.
Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir.
INFECTIOUS DISEASES . 51(4): 1-6. Nº de citas: 2
-
Sánchez-Conde M, Rodriguez-Centeno J, Dronda F, López JC, Jiménez Z, Berenguer J, Pérez-Elías MJ, Moreno S, Rodés B, Brañas F.
Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population.
Epigenomics . 11(5): 501-509. Nº de citas: 11
-
Rodríguez-Muñoz J, Moreno S.
Strategies for the cure of HIV infection.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(4): 265-273. Nº de citas: 3
-
Ercibengoa M, Goenaga MA, Ardanuy C, Grau I, García-de-la-Maria C, Almela M, Miro JM, Navas E, Fariñas MC, de Alegría CR, de la Torre J, Fernández F, Marín M, Muñoz P, Orden B, Oteo JA, García-Álvarez L, de Alarcón A, Jiménez JAL, Marimón JM.
Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis.
BMC INFECTIOUS DISEASES . 19(1): 291-291. Nº de citas: 4
-
Gutiérrez C, Lopez-Abente J, Pérez-Fernández V, Prieto-Sánchez A, Correa-Rocha R, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.
Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients.
Plos One . 14(3): . Nº de citas: 5
-
Perez-Molina, Jose A., Polo, Rosa, Lopez-Aldeguer, Jose, Lozano, Fernando, Aguirrebengoa, Koldo, Ramon Arribas, Jose, Boix, Vicente, Berenguer, Juan, Ramon Blanco, Jose, Domingo, Pere, Estrada, Vicente, Jose Galindo, Maria, Garcia, Federico, Maria Gatell, Jose, Gonzalez-Garcia, Juan, Gutierrez, Felix, Antonio Iribarren, Jose, Knobel, Hernando, Maria Llibre, Josep, Carlos Lopez-Bernaldo de Quiros, Juan, Fernando Lopez-Cortes, Luis, Emilio Losa, Juan, Marino, Ana, Miro, Jose M., Montes, Maria L., Moreno, Santiago, Negredo, Eugenia, Perez-Elias, Maria J., Podzamczer, Daniel, Portilla, Joaquin, Poveda, Eva, Pulido, Federico, Ribera, Esteban, Rivero, Antonio, Rubio, Rafael, Santos, Jesus, Sanz-Moreno, Jose, Sanz-Sanz, Jesus, Serrano, Sergio, de la Torre, Javier, Tuset, Montserrat, von Wichman, Miguel A., Martinez, Esteban, Spanish Soc Infect Dis Clinical, Natl AIDS Plan.
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(3): 195-202. Nº de citas: 10
-
Mitsuwan, Watcharapong, Jimenez-Munguia, Irene, Visutthi, Monton, Sianglum, Wipawadee, Jover, A., Barcenilla, F., Garcia, M., Pujol, M., Gasch, O., Dominguez, M. A., Camoez, M., Duenas, C., Ojeda, E., Martinez, J. A., Marco, F., Chaves, F., Lagarde, M., Lopez-Medrano, F., Montejo, J. M., Bereciertua, E., Hernandez, J. L., von Wichmann, M. A., Goenaga, A., Garcia-Arenzana, J. M., Padilla, B., Padilla, C., Cercenado, E., Garcia-Prado, G., Tapiol, J., Horcajada, J. P., Montero, M., Salvado, M., Arnaiz, A., Fernandez, C., Calbo, E., Xercavins, M., Granados, A., Fontanals, D., Pintado, V, Loza, E., Torre-Cisneros, J., Lara, R., Rodriguez-Lopez, F., Natera, C., Blanco, J. R., Olarte, I, Benito, N., Mirelis, B., Murillas, J., Ruiz de Gopegui, E., Espejo, H., Morera, M. A., Rodriguez-Bano, J., Lopez-Cortes, L. E., Pascual, A., Martin, C., Lepe, J. A., Molina, J., Sorde, R., Almirante, B., Larrosa, N., Rodriguez-Ortega, Manuel J., Voravuthikunchai, Supayang P..
Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles
MICROBIAL PATHOGENESIS . 128: 112-118. Nº de citas: 5